Heart medtech Anteris raises $39m to fund clinical strategy
SYDNEY: Anteris Technologies, a dual-listed heart medtech backed by L1 Capital and New ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
